A detailed history of Geode Capital Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,260,050 shares of BMRN stock, worth $212 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,260,050
Previous 3,199,358 1.9%
Holding current value
$212 Million
Previous $263 Million 13.0%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$69.02 - $93.84 $4.19 Million - $5.7 Million
60,692 Added 1.9%
3,260,050 $229 Million
Q2 2024

Aug 09, 2024

BUY
$74.43 - $92.22 $15.8 Million - $19.6 Million
212,643 Added 7.12%
3,199,358 $263 Million
Q1 2024

May 13, 2024

BUY
$83.81 - $99.0 $9.58 Million - $11.3 Million
114,283 Added 3.98%
2,986,715 $261 Million
Q4 2023

Feb 13, 2024

BUY
$76.22 - $98.51 $8.38 Million - $10.8 Million
109,996 Added 3.98%
2,872,432 $277 Million
Q3 2023

Nov 13, 2023

BUY
$85.07 - $94.48 $4.37 Million - $4.86 Million
51,411 Added 1.9%
2,762,436 $244 Million
Q2 2023

Aug 11, 2023

BUY
$86.68 - $100.3 $4.24 Million - $4.9 Million
48,902 Added 1.84%
2,711,025 $235 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $6.85 Million - $9.15 Million
78,019 Added 3.02%
2,662,123 $259 Million
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $5.63 Million - $7.56 Million
69,581 Added 2.77%
2,584,104 $267 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $3.51 Million - $4.14 Million
42,707 Added 1.73%
2,514,523 $213 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $1.26 Million - $1.53 Million
17,579 Added 0.72%
2,471,816 $205 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $4.08 Million - $5.09 Million
54,894 Added 2.29%
2,454,237 $189 Million
Q4 2021

Feb 11, 2022

BUY
$71.72 - $91.47 $5.48 Million - $6.99 Million
76,459 Added 3.29%
2,399,343 $212 Million
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $1.04 Million - $1.19 Million
13,962 Added 0.6%
2,322,884 $179 Million
Q2 2021

Aug 13, 2021

BUY
$75.51 - $84.79 $10.6 Million - $11.9 Million
140,877 Added 6.5%
2,308,922 $192 Million
Q1 2021

May 12, 2021

BUY
$74.73 - $90.69 $8.29 Million - $10.1 Million
110,904 Added 5.39%
2,168,045 $163 Million
Q4 2020

Feb 12, 2021

BUY
$72.61 - $90.2 $5.03 Million - $6.25 Million
69,325 Added 3.49%
2,057,141 $180 Million
Q3 2020

Nov 13, 2020

SELL
$71.87 - $131.03 $6.94 Million - $12.7 Million
-96,620 Reduced 4.64%
1,987,816 $151 Million
Q2 2020

Aug 13, 2020

BUY
$79.55 - $124.22 $170,475 - $266,203
2,143 Added 0.1%
2,084,436 $257 Million
Q1 2020

May 14, 2020

BUY
$71.37 - $96.85 $10.5 Million - $14.2 Million
146,481 Added 7.57%
2,082,293 $176 Million
Q4 2019

Feb 13, 2020

BUY
$64.27 - $86.37 $6.92 Million - $9.29 Million
107,612 Added 5.89%
1,935,812 $164 Million
Q3 2019

Nov 12, 2019

BUY
$67.4 - $85.11 $1.44 Million - $1.81 Million
21,321 Added 1.18%
1,828,200 $123 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $4.24 Million - $4.96 Million
52,797 Added 3.01%
1,806,879 $155 Million
Q1 2019

May 14, 2019

BUY
$84.2 - $98.62 $9.31 Million - $10.9 Million
110,575 Added 6.73%
1,754,082 $156 Million
Q4 2018

Feb 13, 2019

BUY
$80.14 - $106.07 $7.41 Million - $9.81 Million
92,519 Added 5.97%
1,643,507 $140 Million
Q3 2018

Nov 13, 2018

BUY
$93.92 - $105.72 $2.12 Million - $2.39 Million
22,596 Added 1.48%
1,550,988 $150 Million
Q2 2018

Aug 14, 2018

BUY
$76.01 - $99.03 $4.29 Million - $5.59 Million
56,446 Added 3.83%
1,528,392 $144 Million
Q1 2018

May 15, 2018

BUY
$77.67 - $92.63 $2 Million - $2.39 Million
25,767 Added 1.78%
1,471,946 $119 Million
Q4 2017

Feb 13, 2018

BUY
$80.76 - $95.13 $1.54 Million - $1.81 Million
19,011 Added 1.33%
1,446,179 $129 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $1.96 Million - $2.31 Million
24,328 Added 1.73%
1,427,168 $133 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,402,840
1,402,840 $127 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.